Incidence and Recurrence Rates of Colorectal Adenomas: A Prospective Study

Size: px
Start display at page:

Download "Incidence and Recurrence Rates of Colorectal Adenomas: A Prospective Study"

Transcription

1 GASTROENTEROLOGY 1995;108: Incidence and Recurrence Rates of Colorectal : A Prospective Study ALFRED I. NEUGUT,*'* JUDITH S. JACOBSON,* HABIBUL AHSAN,* JASON SANTOS,* GAlL C. GARBOWSKI,* KENNETH A. FORDE, MICHAEL R. TREAT, ~ and JEROME WAYE Departments of *Medicine and Surgery and ~School of Public Health, College of Physicians and Surgeons, Columbia University, New York; and lidepartment of Medicine, Mount Sinai School of Medicine, New York, New York Background/Aims: The frequency of colorectal adenomas, the precursor lesions for most cases of colorectal carcinoma, has been generally measured as prevalence rates of adenomas at autopsy or colonoscopy. The aim of this study was to estimate the incidence rate of adenomas and compare it with the adenoma recurrence rate. Methods: Data on colonoscopies performed in three New York City practices were collected prospectively. The cumulative rate of adenoma diagnosis on repeat colonoscopy was calculated for patients with no abnormalities on index colonoscopy ("incidence" rate) and for patients with adenomas on the index co- Ionoscopy ("recurrence" rate). Results: The cumulative incidence rate of adenomas at 36 months was 16%, and the cumulative recurrence rate at 36 months was 42% (P < 0.004). The recurrence rate was higher in patients with multiple adenomas than in those with a single adenoma on index colonoscopy, although the increase was not statistically significant. Conclusions: Although the recurrence rate has always been assumed to be elevated, this study is the first to compare the recurrence rate of adenomas with the incidence rate directly and to show that the recurrence rate is indeed elevated. A denomatous polyps (adenomas) are benign tumors that are widely recognized as precursor lesions for the vast majority of colorectal cancers. 1'2 Because they are generally asymptomatic, their frequency in different populations has generally been described in terms of prevalence rates rather than incidence rates. Before the mid-1980s, studies of adenoma prevalence were based on consecutive autopsies in which the entire large bowel was examined More recently, adenoma prevalence rates have been derived from colonoscopy studies of symptomatic or high-risk individuals. 2'16-25 Most recently, several colonoscopy screening studies have been performed among asymptomatic average-risk individuals Since the 1970s, it has been known that patients who have had an adenoma are likely to have another. Patients whose adenomas were removed have been found to have a 15%-60% risk for a new, metachronous, or recurrent adenoma within 3-4 years after the previous polypectomy. 2'29-37 In particular, the National Polyp Study showed a recurrence rate of 32% at 3 years9 The recurrence rate has generally been assumed to be higher than the incidence rate in those without prior colorectal neoplasia. Indeed, because recurrence is so common, it has been used as a surrogate end point for invasive colorectal cancer in randomized chemoprevention trials Actual adenoma incidence rates can be determined only by serial examinations of the colon in a population without a history of colorectal neoplasia. In a recent study, Rex et al. 43 did this using sigmoidoscopy and found a 6% incidence of left-sided adenomas after 3 years. No prior study has reported the results of serial colonoscopies in a population where the initial colonoscopy result was negative. Between 1986 and 1988, we collected data on patients undergoing colonoscopy in three colonoscopy practices in New York City. Some of the patients who had negative results on colonoscopies and no prior colorectal neoplasia underwent repeat colonoscopy. In this paper, we report the results of these reexaminations as actual adenoma incidence rates. In addition, we calculated the incidence of metachronous adenomas (the recurrence rate) for patients who initially had adenomas and who subsequently underwent colonoscopy. As a result, we are able to compare the adenoma recurrence rate with the adenoma incidence rate. Materials and Methods As part of a study of risk factors for colorectal adenomatous polyps, we collected clinical and demographic data on all patients undergoing colonoscopy in three colonoscopy practices in New York City between April 1986 and March The total number of patients who underwent colonoscopy was Of them, 2443 (81.8%) were eligible for our study. To 1995 by the American Gastroenterological Association /95/$3.00

2 February 1995 COLORECTAL ADENOMA INCIDENCE AND RECURRENCE 403 be eligible, patients had to be between the ages of 35 and 84 years; had to reside in New York, New Jersey, or Connecticut; had to be English or Spanish speaking; and had to undergo colonoscopy that extended at ieast to the splenic flexure (in fact, more than 90% of study participants underwent colonoscopy extending to the cecum). Data sheets indicating the reasons for colonoscopy and the clinical findings were completed by the colonoscopist at the time of colonoscopy. Pathology slides on all suspected neoplastic lesions were reviewed by the study pathologist (Dr. Cecilia Fenoglio-Preiser of the University of Cincinnati Medical School). The details of this study are described elsewhere All eligible subjects were contacted by letter and telephone regarding interview. Ultimately, 2001 were successfully interviewed. Of these 2001 patients, 299 were found to have one or more pathologically defined adenomas with no prior history of colon carcinoma, adenomatous polyps, or inflammatory bowel disease. They formed the case group for our case-control study and were compared with the control group, which consisted of 508 individuals who had no colorectal neoplasia on the index colonoscopy and no history of colorectal neoplasia or inflammatory bowel disease. Subsequent to this case-control study, we continued to collect clinical data sheets documenting the findings at colonoscopy for these patients. Data collection and data entry were complete through the end of We used Cox proportional hazards modeling using the BMDP Statistical Software Package (BMDP Statistical Software, University of California Press, Los Angeles, CA) to compare the recurrence rates of adenomas with the incidence rates of adenomas, controlling for age, sex, and education. Cumula- tive incidence and recurrence rates were estimated from the curves generated as above. Results Of the 508 patients who had no abnormalities on their index colonoscopy, 99 (19.4%) underwent a repeat colonoscopy within the follow-up period. Of the 299 patients with an adenoma on their index colonoscopy, 178 (59.5%) underwent repeat colo,loscopy. The time intervals between colonoscopies varied. Table 1 shows demographic data on patients who underwent repeat colonoscopy and those who did not in the initial normal and initial adenoma groups. The patients with no abnormalities on initial colonoscopy who underwent followup were comparable with those who did not undergo repeat colonoscopy in sex and age distribution (Table 1). However, those who underwent repeat colonoscopy were more educated (P = 0.008) and more likely to be white (P = 0.005). Patients who had an adenoma on initial colonoscopy and underwent repeat colonoscopy also were similar in sex distribution but slightly younger than those who did not undergo follow-up colonoscopy. Their educational level was somewhat higher than that of patients who did not undergo repeat colonoscopy (P = 0.12), but the difference was not as great as for the initially normal group. Race distribution was similar for both adenoma groups. Table 2 shows data on clinical variables in the study population, including indications for initial and Table 1. Demographic Characteristics of Patients Who Underwent Repeat Colonoscopy and Those Who Did Not Index colonoscopy Normal results With follow-up Without follow-up With follow-up Without follow-up Sex (%) Male 46 (46.5) 179 (43.8) 102 (57.3) 71 (58,7) Female 53 (53.5) 230 (56.2) 76 (47.2) 50 (41.3) Age (yr [%]) (38.4) 149 (36.4) 38 (21.3) 18 (14.9) (33,3) 124 (30.3) 56 (31.5) 42 (34.7) (28.3) 136 (33.3) 84 (47.2) 61 (50.4) Median age Education (%) High school graduate or less 16 (16.2) 138 (33.8) 55 (30.0) 44 (36.4) Some college 19 (19.2) 69 (16.9) 20 (11.2) 22 (18.2) College graduate 21 (21.2) 52 (12.7) 42 (23.6) 21 (17.4) Postgraduate training 43 (43.4) 149 (36.5) 61 (34.3) 34 (28.1) Race (%) Black 2 (2.0) 41 (10.1) 9 (5.1) 10 (8.3) Hispanic 3 (3.0) 29 (7.1) 6 (3.4) 2 (1.6) White 92 (92.9) 333 (81.6) 159 (90.3) 108 (89.2) Asian 2 (2.0) 4 (1.0) Other -- 1 (0.2) 2 (1.1) 1 (0.8)

3 404 NEUGUT ET AL. GASTROENTEROLOGY Vol. 108, No. 2 follow-up colonoscopy. Among patients who underwent follow-up colonoscopy, rectal bleeding or other gastrointestinal symptoms were indications for the initial procedure in 44.4% of patients with no abnormalities initially and 43.8% of those with an adenoma on index colonoscopy. For the follow-up procedure, the main indications for the group with no abnormalities initially were rectal bleeding or other gastrointestinal symptoms (38.8%) and family history (32.6%). Among patients with adenomas on index colonoscopy, 94.9% underwent follow-up colonoscopy for surveillance. The percentage of patients with multiple adenomas on the index colonoscopy and the degree of dysplasia on the index colonoscopy for those who did and did not have follow-up were comparable (Table 2). The main results of the study are shown in Figure 1 and Table 3. The recurrence rate was significantly higher than the incidence rate. By the end of the follow-up period (mean, 34 months), 24% of patients with negative colonoscopy results initially (24 of 99) had developed a new adenoma and 46% of patients with adenoma initially (81 of 178) had had a recurrent adenoma. Figure 2 divides the initial adenoma group into those with a single adenoma on the index colonoscopy and those with multiple adenomas on the index colonoscopy. Unsurprisingly, risk of a new adenoma was highest in 100 A o~ 80 Q) U r, w 60 "0 "6 F-,>w 40 E u 2o lie E* E E X BE X EB X i l l l l l X X X x X X X **** I I I I I I I Time (Months) Figure 1. Cumulative incidence rates of adenomatous polyps by time interval after initial colonoscopy. I, polyps; x, normal. *P = the group that had multiple adenomas initially; risk in those with a single initial adenoma was lower but higher than that in patients who had no abnormalities on the index colonoscopy. Those with three or more adenomas had a higher recurrence rate, but the numbers were too small for statistical significance. When stratified by indication for follow-up colonoscopy, the recurrence rate remained higher than the incidence rate in every category *E Table 2. Clinical Characteristics of Patients Who Underwent Repeat Colonoscopy and Those Who Did Not Index colonoscopy Normal results With follow-up Without follow-up With follow-up Without follow-up Indications for index colonoscopy (%) Surveillance, screening Rectal bleeding Other gastrointestinal symptoms Family history Other indications Indications for first follow-up colonoscopy (%) Surveillance, screening Rectal bleeding Other gastrointestinal symptoms Family history Other indications No. of adenomas on index colonoscopy (%) >3 Degree of dysplasia on index colonoscopy (%) None or mild Moderate Severe Carcinoma in situ Intramucosal cancer 3 (3.0) 31 (31.3) 13 (13.1) 37 (37.4) 15 (15.2) 18 (18.4) 28 (28.6) 10 (10.2) 32 (32.6) 10 (10.2) 1 (0.2) 153 (37.6) 72 (17.7) 76 (18.7) 105 (25.8) 11 (6.2) 61 (34.3) 17 (9.5) 19 (10.7) 70 (39.3) 169 (94.9) 5 (2.8) 2 (1.1) 0 (0.0) 2 (1.1) 105 (66.5) 33 (20.9) 20 (12.6) 148 (93.7) 5 (3.2) 2 (1.3) 2 (1.3) 1 (o.5) 2 (1.6) 38 (31.4) 7 (5.8) 9 (7.4) 65 (53.7) 80 (66.1) 31 (25.6) 10 (&3) 114 (94.2) 6 (5.0) 1 (0.8) 0 (0.0) 0 (0.0)

4 February 1995 COLORECTAL ADENOMA INCIDENCE AND RECURRENCE 405 Table 3. Cumulative Incidence of No abnormalities on index colonoscopy on index colonoscopy Total Total no. of patients followed up 99 Men 46 Women 53 No. of adenomas on index colonoscopy >3 Indications for first follow-up colonoscopy Surveillance, screening 18 Rectal bleeding and/or other gastrointestinal symptoms 38 Family history 32 Other indications 10 on follow-up (%) Total on follow-up (%) 24 (24.0) (45.5) 9 (19.6) (48.0) 15 (28.3) (42.2) (41.9) (48.5) (65.O) 4 (22.2) (45.0) 4 (10.5) 7 3 (42.9) 11 (34.4) 0 0 (0.0) 5 (50.0) 2 2 (100.0) except family history. Recurrence rates were higher than incidence rates in all age groups in men and in women aged years (Table 4). Table 5 shows the index incidence rate and recurrence rate for adenomas by time interval after the index colonoscopy. As can be seen, the incidence rate up to 53 months is in the 17.5%-30% range, and the recurrence rate ranges from 28.6% to 39.5%. Among the 10 study participants who had follow-up after 53 months, only 1 had previously had an adenoma. Of the 9 who had not, 4 had an adenoma at months. Discussion Because of the difficulty in diagnosing adenomatous polyps and the general absence of symptoms associ- A,0 m ',~,_c m > 0 E O 4o 2O AA xx: AA X AA AA AA AA X Hi AAA X Ill A~X MI ** IlilliI *Alll 0 ---* ** *nil i I I I I I I Time (Months) Figure 2. Cumulative incidence rates of adenomatous polyps by time interval after initial colonoscopy, x, 1 adenomatous polyp; A, >1 adenomatous polyp; I, no adenomatous polyps. *P = *I IX *x 72 ated with them, true incidence rates have not previously been available. Results of repeated colonoscopy in individuals with normal results on initial examinations have not been reported. In this study, we present, to our knowledge, the first published data on incidence rates for colorectal adenomas. Rates of recurrence (or incidence of metachronous adenomas) have been reported in the past, but no prior study has directly compared the recurrence rate with the incidence rate in previously neoplasia-free individuals. This study shows that recurrence rates are indeed elevated compared with the incidence rate in normal individuals. This finding is reassuring inasmuch as it is known that postpolypectomy patients are known to have an elevated risk for colorectal cancer 2'33'47-52 and should therefore have an increased risk for metachronous adenomas as well. Our finding strengthens support for use of the adenoma recurrence rate as a surrogate end point in colon cancer chemoprevention trials The recurrence rate shown in this study is comparable with the rate previously described by our group in a similar population 34 as well as with the general range of recurrence rates in the literature However, the study has several limitations. The most obvious and important is the selection of the patients who underwent repeat colonoscopy. Less than one-fifth of the patients with initially normal results on colonoscopy underwent repeat colonoscopy. These patients probably are not representative of the entire cohort with initially normal results. They may have had persistent, recurrent, or new symptoms or a particularly high level of anxiety. The subgroup who underwent repeat colonoscopy had a higher educational level than those who did not have

5 406 NEUGUT ET AL. GASTROENTEROLOGY Vol. 108, No. 2 repeat colonoscopy. This sort of selection bias would probably be present in any study in which the incidence rate was generated from a screening program. Colorectal cancer has been associated with markers of high socioeconomic status in most populations, 53 but socioeconomic status is difficult to assess as a risk factor for adenomas because patients who undergo colonoscopy without having cancer are likely to be relatively well educated and insured. Another important limitation of this study is that the patients undergoing colonoscopy are not, for the most part, asymptomatic average-risk individuals. Most had an indication for the index colonoscopy: rectal bleeding, either occult or overt, other symptoms, or family history. Our prior study of this population did not show a significant variation in the prevalence of adenomas on index colonoscopy by symptom, nor was the prevalence of adenomas significantly higher in symptomatic than asymptomatic individuals. 46 Apparently, most adenomas diagnosed at colonoscopy are an incidental finding and not the cause of the symptoms that led to the colonoscopy. Thus, the prevalence or incidence rate of adenomas in this population undergoing colonoscopy may not be significantly different from what one might expect in the general population. The prevalence rate of adenomas in asymptomatic average-risk subjects in our population 25 was comparable with prevalence rates previously described in colonoscopy screening studies of asymptomatic average-risk individuals In the present study, patients with and without adenomas on index colonoscopy differed in the distribution of indications for follow-up. However, for each indication except family history, which is not an indication for colonoscopy in patients with a personal history of neoplasia, the recurrence rate was higher than the incidence rate. The patients with no abnormalities initially underwent recolonoscopy primarily because of symptoms, whereas the patients with adenomas underwent recolonoscopy for surveillance purposes (Table 2). Thus the difference between these two groups in follow-up yield is a conservative finding. Table 4. Cumulative Incidence and Recurrence Rates of by Sex and Age at Index Colonoscopy Men Women Age (yr) Adenoma (%) Normal (%) Adenoma (%) Normal (%) <55 9/25 (36.0) 4/18 (22.2) 2/13 (15.4) 4/20 (20.0) /29 (31.0) 2/15 (13.3) 14/27 (51.9) 4/18 (22.2) -->65 31/48 (64.6) 3/13 (23.1) 16/36 (44.4) 7/15 (46.7) Table 5. Incidence Rate and Recurrence Rate of by Time Interval Following Index Colonoscopy Index colonoscopy Normal results Adenoma Time interval No. No. (mo) scoped Recurrences scoped Recurrences The relatively high (34.4%) adenoma incidence rate in patients with no previous abnormalities who had a family history of colorectal cancer may have implications for screening intervals in this subgroup of patients. Other findings in this study are consistent with those of past studies. For example, the recurrence rate was higher among patients with multiple adenomas at index colonoscopy than for those with a single adenoma at index colonoscopy. It is estimated that up to 10% of adenomas are missed on a single colonoscopy. 54 Thus, some of the incidence rate may represent missed adenomas; however, we are unable to quantify this error. In summary, our study gives the first estimates of incidence rates for colorectal adenomatous polyps, with a cumulative incidence of approximately 16% after 3 years. The incidence rate of metachronous adenomas, or recurrence rate, was significantly higher than the initial adenoma incidence rate and was higher for those with multiple adenomas at initial polypectomy than for those with a single adenoma. Despite the selection factors in the overall patient population and the selection biases among patients undergoing repeat colonoscopy, these incidence and recurrence estimates appear to be consistent with prior studies and the understanding of the natural history of colorectal neoplasia. This information should be useful in the design of future chemoprevention trials and in the development recommendations for colorectal cancer screening. References 1. Jackman R J, Mayo CW. The adenoma-carcinoma sequence and cancer of the colon. Surg Gynecol Obstet 1951; 93: Neugut AI, Jacobson JS, DeVivo I. Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prey 1993; 2: Williams AR, Balasoorrya BAW, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982;23:

6 February 1995 COLORECTAL ADENOMA INCIDENCE AND RECURRENCE Clark JC, Collan Y, Eide T J, Esteve J, Ewens S, Gibbs NM, Jensen OM, Koskela E, MacLennan R, Simpson JG, Stalsberg H, Zoridze DG. Prevalence of polyps in an autopsy series from areas with varying incidence of large bowel cancer. Int J Cancer 1985;36: Helwig EB. The evolution of adenomas of the large intestine and their relation to carcinoma. Surg Gynecol Obstet 1947;84: Bombi JA. Polyps of the colon in Barcelona, Spain: an autopsy study. Cancer 1988;61: Coode PE, Chan KW, Chan YT. Polyps and diverticula of the large intestine: a necropsy survey in Hong Kong. Gut 1985; 26: Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo. Cancer 1982;49: Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasch JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 1979; 43: Haghighi P, Nasr K, Molhallatee EA, Ghassemi H, Sadri S, Nabizadeh I, Sheikholeslami MH, Mostajawi N. Colorectal polyps and carcinoma in southern Iran. Cancer 1977;39: Marigo C, Correa P, Haenszel W. Cancer and "cancer related" colorectal lesions in Sao Paulo, Brazil. 1978;22: Stemmermann GN, Yatani R. Diverticulosis and polyps of the large intestine. Cancer 1973; 31: Restrepo C, Correa P, Duque E, Quello C. Polyps in a low risk colonic cancer population in Colombia, South America. Dis Colon Rectum 1981; 24: Sate E, Ouchi A, Sasano N, Ishidate T. Polyps and diverticulosis of the large bowel in an autopsy population of Akita Prefecture compared with Miyagi: high risk for colorectal cancer in Japan. Cancer 1976; 37: Correa P, Strong JP, Reif A, Johnson WD. The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer 1977; 39: Shimoda T, Ikegami M, Fujisaki J, Matsui T, Aizawa S, Ishikawa E. Early colorecta[ carcinoma with special reference to its development de novo. Cancer 1989;64: Webb WA, McDaniel L, Jones L. Experience with one thousand colonoscopic polypectomy. Ann Surg 1985;201: Granquist S. Distribution of polyps in the large bowel in relation to age. Scand J Gastroenterol 1981; 16: Gillespie PE, Chambers T J, Chan KW, Doronze F, Morson BC, Williams CB. Colonic adenomas--a colonoscopy survey. Gut 1979; 20: Bat L, Pines A, Ron E, Rosenblum Y, Niv Y, Shemesh E. Colorectal adenomatous polyps and carcinoma in Ashkenazi and non-ashkenazki Jews in Israel. Cancer 1986;58: Wegener M, Borsch G, Schmidt G. Colorectal adenomas: distribution, incidence of malignant transformation, and rate of recurrence. Dis Colon Rectum 1986;29: O'Brien M J, Winawer S J, Zauber AG, O'Brien M J, Winawar S J, Zanber AG, Gottlieb LS, Sternberg SS, Diaz B, Dickersin R, Ewing S, Geller S, Kasimian D, Komorovski R, Sazporn A, and The National Polyp Study Work Group. The National Polyp Study: patient and polyp characteristics associated with high-grade dysplasias in colorectal adenomas. Gastroenterology 1990;98: Morini S, DeAngelis P, Manurita L, Colovolpe V. The association of colonic diverticula with adenomas and carcinomas: a colonescopic experience. Dis Colon Rectum 1988;31: Neugut AI, Garbowski GC, Waye JG, Forde KA, Treat MR, Tsai JL, Lee WC. Diagnostic yield of colorectal neeplasia with the use of colonoscopy for abdominal pain, change in bowel habits, and rectal bleeding. Am J Gastroenterol 1993;88: Guillem JG, Forde KA, Treat MR, Neugut AI, O'Toole MR, Diamond BE. Colonoscopic screening for neoplasms in asymptomatic firstdegree relatives of colon cancer patients: a controlled, prospective study. Dis Colon Rectum 1992;35: DiSario JA, Foutch G, Mai HD, Pardy K, Manne RK. Prevalence and malignant potential of colorectal polyps in average-risk men. Am J Gastroenterol 1991; 86: Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastreenterol 1991;86: Rex DK, Lehman GA, Hawes RH, AIbright GM, Smith JJ. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood cell tests. Gastroenterology 1991;100: Henry LG, Condon RE, Schulte W J, Aprahamian 6, DeCosse JJ. Risk of recurrent colon polyps. Ann Surg 1975; 182: Fowler DL, Hedberg SE. Follow-up colonoscopy after polypectomy (abstr). Gastrointest Endosc 1980;26: Winawer SJ. Follow-up after polypectomy. World J Surg 1991; 15: Waye JD, Braunfeld S. Surveillance intervals after colonoscopic polypectomy. Endoscopy 1982; 14: Morson BC. The evolution of colorectal carcinoma. Clin Radiol 1984;35: Neugut AI, Johnsen CM, Forde KA, Treat MR. Recurrence rates for colorectal polyps. Cancer 1985;55: Matek W, Guggenmoos-Holzmann I, Demling L. Follow-up of patients with colorectal adenomas. Endoscopy 1985;17: Kronborg O, Fenger C. Prognostic evaluation of planned followup of patients with colorectal adenomas. Int J Colorectal Dis 1987;2: Grossman S, Miles ML, Tekawa IS, Jewell NP. Colonscopic screening of persons with suspected risk factors for colon cancer.. Past history of colorectal neoplasms. Gastroenterology 1989;96: Winawer S J, Zauber AG, O'Brien M J, He MN, Gottlieb L, Sternberg SS, Waye JD, Bond J, Schapiro M, Stewart ET, Panish J, Ackroyd I, Kurtz RC, Shike M, and The National Polyp Study Work Group. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps: the National Polyp Study Workgroup. N Engl J Med 1993;328: McKeown-Eyssen G, Holloway AYC, Jazmaji V, Bright-See E, Dion P, Bruce WR. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 1988;48: MacLennan R, Bain C, Macrae F, Gratten 14, Battistutta D, Bokey EL, Chapuis P, Goulston K, Lambert J, Wahlqvist M, Wald M. Design and implementation of the Australian Polyp Prevention Project. Front Gastrointest Res 1991; 18: Lubin F, Boeing H, Rozen P. Design and background of the Tel Aviv-Heidelberg dietary study of colonic adenoma patients and calcium intervention trial. Front Gastrointest Res 1991; 18: Schatzkin A, Schiffman M, Lanza E. Research priorities in large bowel cancer prevention. Semin Oncol 1990;17: Rex DK, Lehman GA, Ulbright TM, Smith J J, Hawes RH. The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination. Gastroenterology 1994; 106: Neugut AI, Garbowski GC, Lee WC, Murray T, Nieves JW, Forde KA, Treat MR, Waye JD, Fenoqlio-Preiser C. Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps: a case-control study. Ann Intern Med 1993; 118: Lee WC, Neugut AI, Garbowski GC, Forde KA, Treat MR, Waye JD, Fenoqlio-Preiser C. Cigarettes, alcohol, coffee and caffeine

7 408 NEUGUT ET AL. GASTROENTEROLOGY Vol. 108, No. 2 as risk factors for colorectal adenomatous polyps. Ann Epidemiol 1993; 3: Neugut AI, Garbowski GC, Waye JD, Forde KA, Treat MR, Tsai JL, Lee WC. Diagnostic yield of colorectal neoplasia with the use of colonoscopy for abdominal pain, change in bowel habits, and rectal bleeding. Am J Gastroenterol 1993;88: , Brahme F, Ekelund GR, Norden JG, Wenckert A. Metachronous colorectal polyps: comparison of development of colorectal polyps and carcinomas in persons with and without histories of polyps. Dis Colon Rectum 1974; 17: , Rider JA, Kirsner JB, Moeller HC, Palmer WL. Polyps of the colon and rectum: their incidence and relationship to carcinoma. Am J Med 1954; , Weakley FL, Swinton NW. Follow-up study of patients with benign mucosal polyps of the rectum. Dis Colon Rectum 1962;5: , Koppel M, Bailar JC, Weakley FL, Shimkin MB. Incidence of cancer in the colon and rectum among polyp free patients. Dis Colon Rectum 1962;5: Lotfi AM, Spencer R J, Ilstrup DM, Melton J. Colorectal polyps and the risk of subsequent carcinoma. Mayo Clin Proc 1986; 61: Olsen HW, Lawrence WA, Snook CW, Mutch WM. Review of recurrent polyps and cancer in 500 patients with initial colonoscopy for polyps. Dis Colon Rectum 1988;31: Schottenfeld D, Winawer SJ. Large intestine, In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention, Philadelphia: Saunders, 1982: Hixson L J, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss rate of large colorectal polyps. Gastrointest Endosc 1991;37: Received April 22, Accepted September 13, Address requests for reprints to: Alfred I. Neugut, M.D., Ph.D., Division of Oncology, Columbia-Presbyterian Medical Center, 630 West 168th Street, New York, New York

C olorectal adenomas are reputed to be precancerous

C olorectal adenomas are reputed to be precancerous 568 COLORECTAL CANCER Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese Y Yamaji, T Mitsushima, H Ikuma, H Watabe, M Okamoto, T

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Zauber AG, Winawer SJ, O Brien MJ, et al. Colonoscopic polypectomy

More information

ORIGINAL INVESTIGATION

ORIGINAL INVESTIGATION ORIGINAL INVESTIGATION Colon Polyp Recurrence in a Managed Care Population Marianne Ulcickas Yood, DSc, MPH; Susan Oliveria, ScD, MPH; J. Gregory Boyer, PhD; Karen Wells, BS; Paul Stang, PhD; Christine

More information

Colorectal cancer is the second leading cause of cancer-related. Colonoscopic Miss Rates for Right-Sided Colon Cancer: A Population-Based Analysis

Colorectal cancer is the second leading cause of cancer-related. Colonoscopic Miss Rates for Right-Sided Colon Cancer: A Population-Based Analysis GASTROENTEROLOGY 2004;127:452 456 Colonoscopic Miss Rates for Right-Sided Colon Cancer: A Population-Based Analysis BRIAN BRESSLER,* LAWRENCE F. PASZAT,, CHRISTOPHER VINDEN,, CINDY LI, JINGSONG HE, and

More information

50 세미만인구에서용종절제술로제거된대장선종의특성 : 대한장연구학회전향적다기관공동연구

50 세미만인구에서용종절제술로제거된대장선종의특성 : 대한장연구학회전향적다기관공동연구 50 세미만인구에서용종절제술로제거된대장선종의특성 : 대한장연구학회전향적다기관공동연구 The Characteristics of Colorectal Adenoma with Colonoscopic Polypectomy in Population under 50 Years Old: The KASID Prospective Multicenter Study Hyun Joo

More information

The New England Journal of Medicine. IMPORTANCE OF ADENOMAS 5 mm OR LESS IN DIAMETER THAT ARE DETECTED BY SIGMOIDOSCOPY

The New England Journal of Medicine. IMPORTANCE OF ADENOMAS 5 mm OR LESS IN DIAMETER THAT ARE DETECTED BY SIGMOIDOSCOPY IMPORTANCE OF ADENOMAS mm OR LESS THAT ARE DETECTED BY SIGMOIDOSCOPY THOMAS E. READ, M.D., JULIE D. READ, R.N., AND LYNN F. BUTTERLY, M.D. ABSTRACT Background The need for colonoscopy in patients with

More information

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2 Supplementary Table 1. Study Characteristics Author, yr Design Winawer et al., 6 1993 National Polyp Study Jorgensen et al., 9 1995 Funen Adenoma Follow-up Study USA Multi-center, RCT for timing of surveillance

More information

The Prevalence Rate and Anatomic Location of Colorectal Adenoma and Cancer Detected by Colonoscopy in Average-Risk Individuals Aged Years

The Prevalence Rate and Anatomic Location of Colorectal Adenoma and Cancer Detected by Colonoscopy in Average-Risk Individuals Aged Years American Journal of Gastroenterology ISSN 0002-9270 C 2006 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2006.00430.x Published by Blackwell Publishing The Prevalence Rate and Anatomic Location

More information

CLINICAL MANAGEMENT Loren Laine, M.D. Clinical Management Editor University of Southern California Los Angeles, California

CLINICAL MANAGEMENT Loren Laine, M.D. Clinical Management Editor University of Southern California Los Angeles, California GASTROENTEROLOGY 2004;126:1167 1174 CLINICAL MANAGEMENT Loren Laine, M.D. Clinical Management Editor University of Southern California Los Angeles, California Rectal Bleeding and Diminutive Colon Polyps

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 2000, by the Massachusetts Medical Society VOLUME 342 J UNE 15, 2000 NUMBER 24 A COMPARISON OF COLONOSCOPY AND DOUBLE-CONTRAST FOR SURVEILLANCE AFTER POLYPECTOMY

More information

Appendix 1 This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix 1 This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix 1 This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Cenin DR, St John DJB, Ledger MJN, et al. Optimising the

More information

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer David A. Lieberman, 1 Douglas K. Rex, 2 Sidney J. Winawer,

More information

Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema

Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema Bahrain Medical Bulletin, Vol.24, No.3, September 2002 Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema Najeeb S Jamsheer, MD, FRCR* Neelam. Malik, MD, MNAMS** Objective: To

More information

Cost-effectiveness Model for Colon Cancer Screening

Cost-effectiveness Model for Colon Cancer Screening GASTROENTEROLOGY 1995;109:1781-1790 Cost-effectiveness Model for Colon Cancer Screening DAVID A. LIEBERMAN Division of Gastroenterology, Department of Medicine, Oregon Health Sciences University, and Portland

More information

I dence of colorectal cancer in different populations

I dence of colorectal cancer in different populations Polyps of the Colon in Barcelona, Spain An Autopsy Study JOSEP ANTON BOMBI, MD This study is based on a prospective survey of 22 autopsies that was conducted to determine the prevalence of colon adenomas

More information

The Canadian Cancer Society estimates that in

The Canadian Cancer Society estimates that in How Do I Screen For Colorectal Cancer? By Ted M. Ross, MD, FRCS(C); and Naomi Ross, RD, BSc To be presented at the University of Toronto s Primary Care Today sessions (October 3, 2003) The Canadian Cancer

More information

Romanian Journal of Morphology and Embryology 2006, 47(3):

Romanian Journal of Morphology and Embryology 2006, 47(3): Romanian Journal of Morphology and Embryology 26, 7(3):239 23 ORIGINAL PAPER Predictive parameters for advanced neoplastic adenomas and colorectal cancer in patients with colonic polyps a study in a tertiary

More information

IN THE DEVELOPMENT and progression of colorectal

IN THE DEVELOPMENT and progression of colorectal Digestive Endoscopy 2014; 26 (Suppl. 2): 73 77 doi: 10.1111/den.12276 Treatment strategy of diminutive colorectal polyp

More information

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines June 2013 ACRCSP Post Polypectomy Surveillance Guidelines - 2 TABLE OF CONTENTS Background... 3 Terms, Definitions

More information

Structured Follow-Up after Colorectal Cancer Resection: Overrated. R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007

Structured Follow-Up after Colorectal Cancer Resection: Overrated. R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007 Structured Follow-Up after Colorectal Cancer Resection: Overrated R. Taylor Ripley University of Colorado Grand Rounds April 23, 2007 Guidelines for Colonoscopy Production: Surveillance US Multi-Society

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Meester R.G.S, Doubeni CA, Lansdorp-Vogelaar, et al. Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: a microsimulation

More information

Five-Year Risk of Colorectal Neoplasia after Negative Screening Colonoscopy

Five-Year Risk of Colorectal Neoplasia after Negative Screening Colonoscopy The new england journal of medicine original article Five-Year Risk of Colorectal Neoplasia after Negative Screening Colonoscopy Thomas F. Imperiale, M.D., Elizabeth A. Glowinski, R.N., Ching Lin-Cooper,

More information

patients over the age of 40

patients over the age of 40 Postgraduate Medical Journal (1988) 64, 364-368 Frank rectal bleeding: a prospective study of causes in patients over the age of 40 P.S.Y. Cheung, S.K.C. Wong, J. Boey and C.K. Lai Department of Surgery,

More information

Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery

Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation

More information

Large Colorectal Adenomas An Approach to Pathologic Evaluation

Large Colorectal Adenomas An Approach to Pathologic Evaluation Anatomic Pathology / LARGE COLORECTAL ADENOMAS AND PATHOLOGIC EVALUATION Large Colorectal Adenomas An Approach to Pathologic Evaluation Elizabeth D. Euscher, MD, 1 Theodore H. Niemann, MD, 1 Joel G. Lucas,

More information

Preamble. Methods. Ann Intern Med. 1993;119: October 1993 Annals of Internal Medicine Volume 119 Number 8

Preamble. Methods. Ann Intern Med. 1993;119: October 1993 Annals of Internal Medicine Volume 119 Number 8 POSITION PAPER Polyp Guideline: Diagnosis, Treatment, and Surveillance for Patients with Nonfamilial Colorectal Polyps* John H. Bond, MD, for the Practice Parameters Committee of the American College of

More information

Risk Factors for Recurrent High-Risk Polyps after the Removal of High-Risk Polyps at Initial Colonoscopy

Risk Factors for Recurrent High-Risk Polyps after the Removal of High-Risk Polyps at Initial Colonoscopy Original Article Yonsei Med J 2015 Nov;56(6):1559-1565 pissn: 0513-5796 eissn: 1976-2437 Risk Factors for Recurrent High-Risk Polyps after the Removal of High-Risk Polyps at Initial Colonoscopy Hui Won

More information

Colorectal Cancer Screening What are my options?

Colorectal Cancer Screening What are my options? 069-Colorectal cancer (Rosen) 1/23/04 12:59 PM Page 69 What are my options? Wayne Rosen, MD, FRCSC As presented at the 37th Annual Mackid Symposium: Cancer Care in the Community (May 22, 2003) There are

More information

Summary. Cezary ŁozińskiABDF, Witold KyclerABCDEF. Rep Pract Oncol Radiother, 2007; 12(4):

Summary. Cezary ŁozińskiABDF, Witold KyclerABCDEF. Rep Pract Oncol Radiother, 2007; 12(4): Rep Pract Oncol Radiother, 2007; 12(4): 201-206 Original Paper Received: 2006.12.19 Accepted: 2007.04.02 Published: 2007.08.31 Authors Contribution: A Study Design B Data Collection C Statistical Analysis

More information

Incidence and Management of Hemorrhage after Endoscopic Removal of Colorectal Lesions

Incidence and Management of Hemorrhage after Endoscopic Removal of Colorectal Lesions Showa Univ J Med Sci 12(3), 253-258, September 2000 Original Incidence and Management of Hemorrhage after Endoscopic Removal of Colorectal Lesions Masaaki MATSUKAWA, Mototsugu FUJIMORI, Takahiko KOUDA,

More information

Prognosis after Treatment of Villous Adenomas

Prognosis after Treatment of Villous Adenomas Prognosis after Treatment of Villous Adenomas of the Colon and Rectum JOHN CHRISTIANSEN, M.D., PREBEN KIRKEGAARD, M.D., JYTTE IBSEN, M.D. With the existing evidence of neoplastic polyps of the colon and

More information

Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia

Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia The new england journal of medicine original article Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia Philip Schoenfeld, M.D., Brooks Cash, M.D., Andrew Flood, Ph.D., Richard Dobhan,

More information

E Thiis-Evensen, G S HoV, J Sauar, B M Majak, M H Vatn

E Thiis-Evensen, G S HoV, J Sauar, B M Majak, M H Vatn 834 Department of Medicine, Telemark Central Hospital, Skien, Norway E Thiis-Evensen GSHoV J Sauar Department of Pathology, Telemark Central Hospital, Skien, Norway B M Majak Department A of Medicine,

More information

Title Description Type / Priority

Title Description Type / Priority Merit-based Incentive Payment system (MIPS) 2019 Qualified Clinical Data Registry (QCDR) Measure Specifications Summary Listing of QCDR measures supported by the NHCR Measure # NHCR4 NHCR5 GIQIC12 GIQIC15

More information

Prevention and Early Detection of Colorectal Cancer

Prevention and Early Detection of Colorectal Cancer Prevention and Early Detection of Colorectal Cancer JMAJ 44(6): 255 259, 2001 Toshio SAWADA Vice Director, Gunma Prefectural Cancer Center Abstract: Chemoprevention and early detection are key to reducing

More information

Risk of proximal colorectal neoplasia among asymptomatic patients with distal hyperplastic polyps

Risk of proximal colorectal neoplasia among asymptomatic patients with distal hyperplastic polyps The American Journal of Medicine (2005) 118, 1113-1119 CLINICAL RESEARCH STUDY Risk of proximal colorectal neoplasia among asymptomatic patients with distal hyperplastic polyps Otto S. Lin, MD, MSc, a,b

More information

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy

Citation for published version (APA): Wijkerslooth de Weerdesteyn, T. R. (2013). Population screening for colorectal cancer by colonoscopy UvA-DARE (Digital Academic Repository) Population screening for colorectal cancer by colonoscopy de Wijkerslooth, T.R. Link to publication Citation for published version (APA): Wijkerslooth de Weerdesteyn,

More information

Optimal Colonoscopy Surveillance Interval after Polypectomy

Optimal Colonoscopy Surveillance Interval after Polypectomy REVIEW Clin Endosc 2016;49:359-363 http://dx.doi.org/10.5946/ce.2016.080 Print ISSN 2234-2400 On-line ISSN 2234-2443 Open Access Optimal Colonoscopy Surveillance Interval after Polypectomy Tae Oh Kim Department

More information

Feasible economic strategies to improve screening compliance for colorectal cancer in Korea

Feasible economic strategies to improve screening compliance for colorectal cancer in Korea PO Box 2345, Beijing 100023, China World J Gastroenterol 2005;11(11):1587-1593 www.wjgnet.com World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com ELSEVIER 2005 The WJG Press and Elsevier Inc.

More information

Section I Early Colorectal Cancer

Section I Early Colorectal Cancer Section I Early Colorectal Cancer CHAPTER 1 SETTING THE SCENE 1.1 Colorectal Cancer in Australia Colorectal Cancer is unequivocally a major health problem in Australia. It is the most common cancer reported

More information

Sequential screening in the early diagnosis of colorectal cancer in the community

Sequential screening in the early diagnosis of colorectal cancer in the community Journal of Public Health: From Theory to Practice https://doi.org/10.1007/s10389-019-01024-0 ORIGINAL ARTICLE Sequential screening in the early diagnosis of colorectal cancer in the community Ming-sheng

More information

Screening & Surveillance Guidelines

Screening & Surveillance Guidelines Chapter 2 Screening & Surveillance Guidelines I. Eligibility Coloradans ages 50 and older (average risk) or under 50 at elevated risk for colon cancer (personal or family history) that meet the following

More information

Colorectal Adenomas in the Lynch Syndromes. Results of a Colonoscopy Screening Program

Colorectal Adenomas in the Lynch Syndromes. Results of a Colonoscopy Screening Program GASTROENTEROLOGY 1990;98:1117-1122 ALIMENTARY TRACT Colorectal Adenomas in the Lynch Syndromes Results of a Colonoscopy Screening Program STEPHEN J. LANSPA, HENRY T. LYNCH, THOMAS C. SMYRK, PATRICIA STRAYHORN,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Colorectal cancer: colonoscopic surveillance for prevention of colorectal cancer in patients with ulcerative colitis, Crohn

More information

When is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool

When is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool When is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool Adenomas/Carcinoma Sequence Providing Time for Screening Normal 5-20 yrs 5-15 yrs

More information

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy

More information

Colorectal cancer screening: Making sense of the different guidelines

Colorectal cancer screening: Making sense of the different guidelines CANCER DIAGNOSIS AND MANAGEMENT MAURIS MARK MAN, MD, EDITOR CAROL ANN BURKE, MD Department of Gastroenterology, Cleveland Clinic ROSALIND VAN STOLK, MD Director, Center for Colorectal Cancer Prevention,

More information

Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer

Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer Douglas K. Rex, MD, MACG 1, C. Richard Boland, MD 2, Jason A. Dominitz,

More information

Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More Than 20 Years

Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More Than 20 Years ISRN Gastroenterology, Article ID 261302, 4 pages http://dx.doi.org/10.1155/2014/261302 Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More

More information

Increasing the number of older persons in the United

Increasing the number of older persons in the United Current Capacity for Endoscopic Colorectal Cancer Screening in the United States: Data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices Martin L. Brown, PhD, Carrie N.

More information

SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE

SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE The Condition 1. The condition should be an important health problem Colorectal

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer Colorectal Cancer Screening Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson

More information

Colonoscopy with polypectomy significantly reduces colorectal

Colonoscopy with polypectomy significantly reduces colorectal CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:562 567 Utilization and Yield of Surveillance Colonoscopy in the Continued Follow-Up Study of the Polyp Prevention Trial ADEYINKA O. LAIYEMO,*, PAUL F. PINSKY,

More information

Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program

Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2009;7:1335 1340 Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program AASMA SHAUKAT,*, CRISTINA

More information

Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care

Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome DESCRIPTION:

More information

DIGESTIVE SYSTEM SURGICAL PROCEDURES May 1, 2015 INTESTINES (EXCEPT RECTUM) Asst Surg Anae

DIGESTIVE SYSTEM SURGICAL PROCEDURES May 1, 2015 INTESTINES (EXCEPT RECTUM) Asst Surg Anae ENDOSCOPY Z50 Duodenoscopy (not to be claimed if Z399 and/or Z00 performed on same patient within 3 months)... 92.10 Z9 Subsequent procedure (within three months following previous endoscopic procedure)...

More information

R. J. L. F. Loffeld, 1 P. E. P. Dekkers, 2 and M. Flens Introduction

R. J. L. F. Loffeld, 1 P. E. P. Dekkers, 2 and M. Flens Introduction ISRN Gastroenterology Volume 213, Article ID 87138, 5 pages http://dx.doi.org/1.1155/213/87138 Research Article The Incidence of Colorectal Cancer Is Decreasing in the Older Age Cohorts in the Zaanstreek

More information

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change

More information

Colonoscopy Quality Data

Colonoscopy Quality Data Colonoscopy Quality Data www.dhsgi.com Introduction Colorectal cancer is the second leading cause of cancer related deaths in the United States, in men and women combined. In 2016, there are expected to

More information

New Approaches for Early Detection of Ulcerative Colitis (UC) Associated Cancer and Surgical Treatment of UC Patients

New Approaches for Early Detection of Ulcerative Colitis (UC) Associated Cancer and Surgical Treatment of UC Patients New Approaches for Early Detection of Ulcerative Colitis (UC) Associated Cancer and Surgical Treatment of UC Patients Toshiaki Watanabe, M.D., Ph.D. Department of Surgery, Teikyo University School of Medicine,

More information

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth

More information

Colonoscopy is being increasingly used in colorectal

Colonoscopy is being increasingly used in colorectal Are Physicians Doing Too Much Colonoscopy? A National Survey of Colorectal Surveillance after Polypectomy Pauline A. Mysliwiec, MD, MPH; Martin L. Brown, PhD; Carrie N. Klabunde, PhD; and David F. Ransohoff,

More information

Journal of Medicine. The New England

Journal of Medicine. The New England The New England Journal of Medicine Copyright, 2000, by the Massachusetts Medical Society VOLUME 343 J ULY 20, 2000 NUMBER 3 USE OF COLONOSCOPY TO SCREEN ASYMPTOMATIC ADULTS FOR COLORECTAL CANCER DAVID

More information

Korean Type 2 Diabetes Patients have Multiple Adenomatous Polyps Compared to Non-diabetic Controls

Korean Type 2 Diabetes Patients have Multiple Adenomatous Polyps Compared to Non-diabetic Controls ORIGINAL ARTICLE Endocrinology, Nutrition & Metabolism http://dx.doi.org/0.3346/jkms.20.26.9.96 J Korean Med Sci 20; 26: 96-200 Korean Type 2 Diabetes Patients have Multiple Adenomatous Polyps Compared

More information

Screening for colorectal cancer (CRC) has proven effectiveness. Colorectal Cancers Detected After Colonoscopy Frequently Result From Missed Lesions

Screening for colorectal cancer (CRC) has proven effectiveness. Colorectal Cancers Detected After Colonoscopy Frequently Result From Missed Lesions CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:858 864 Colorectal Cancers Detected After Colonoscopy Frequently Result From Missed Lesions HEIKO POHL*,,, and DOUGLAS J. ROBERTSON*,, *Outcomes Group and

More information

Colorectal cancer (CRC) is the second most common

Colorectal cancer (CRC) is the second most common CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2003;1:96 102 First-Degree Relatives of Patients With Advanced Colorectal Adenomas Have an Increased Prevalence of Colorectal Cancer KATHRYN L. LYNCH,* DENNIS J.

More information

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D. Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,

More information

Diverticular disease of the large intestine in Northern Norway

Diverticular disease of the large intestine in Northern Norway Epidemiology Diverticular disease of the large intestine in Northern Norway T. J. EDE' AND HELGE STALSBERG From the nstitute of Medical Biology, University of Troms0, Troms0, Norway Gut, 1979, 20, 609-615

More information

Clinicopathological features of colorectal polyps in 2002 and 2012

Clinicopathological features of colorectal polyps in 2002 and 2012 ORIGINAL ARTICLE Korean J Intern Med 2019;34:65-71 Clinicopathological features of colorectal polyps in 2002 and 2012 Yoon Jeong Nam, Kyeong Ok Kim, Chan Seo Park, Si Hyung Lee, and Byung Ik Jang Division

More information

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls Disclosures: None Jonathan P. Terdiman, M.D. Professor of Clinical Medicine University of California, San Francisco CRC: still a major public

More information

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected

More information

Colonoscopy MM /01/2010. PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient

Colonoscopy MM /01/2010. PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient Colonoscopy Policy Number: Original Effective Date: MM.12.003 12/01/2010 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration 10/01/2017 Section: Surgery Place(s) of Service: Outpatient

More information

The Influence of Snare Size on the Utility and Safety of Cold Snare Polypectomy for the Removal of Colonic Polyps in Japanese Patients

The Influence of Snare Size on the Utility and Safety of Cold Snare Polypectomy for the Removal of Colonic Polyps in Japanese Patients Elmer ress Original Article J Clin Med Res. 2016;8(9):662-666 The Influence of Snare Size on the Utility and Safety of Cold Snare Polypectomy for the Removal of Colonic Polyps in Japanese Patients Hisatsugu

More information

Colorectal cancer (CRC), the second leading cause of

Colorectal cancer (CRC), the second leading cause of GASTROENTEROLOGY 2007;132:96 102 Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis BRIAN BRESSLER,* LAWRENCE F. PASZAT,, ZHONGLIANG CHEN, DEANNA

More information

Research Article Adenoma and Polyp Detection Rates in Colonoscopy according to Indication

Research Article Adenoma and Polyp Detection Rates in Colonoscopy according to Indication Hindawi Gastroenterology Research and Practice Volume 2017, Article ID 7207595, 6 pages https://doi.org/10.1155/2017/7207595 Research Article Adenoma and Polyp Detection Rates in Colonoscopy according

More information

A BS TR AC T. n engl j med 366;8 nejm.org february 23,

A BS TR AC T. n engl j med 366;8 nejm.org february 23, The new england journal of medicine established in 1812 february 23, 2012 vol. 366 no. 8 Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths Ann G. Zauber, Ph.D., Sidney J. Winawer,

More information

Accepted Manuscript. En bloc resection for mm polyps to reduce post-colonoscopy cancer and surveillance. C. Hassan, M. Rutter, A.

Accepted Manuscript. En bloc resection for mm polyps to reduce post-colonoscopy cancer and surveillance. C. Hassan, M. Rutter, A. Accepted Manuscript En bloc resection for 10-20 mm polyps to reduce post-colonoscopy cancer and surveillance C. Hassan, M. Rutter, A. Repici PII: S1542-3565(19)30412-4 DOI: https://doi.org/10.1016/j.cgh.2019.04.022

More information

Screening for Colorectal Cancer in the Elderly. The Broad Perspective

Screening for Colorectal Cancer in the Elderly. The Broad Perspective Screening for Colorectal Cancer in the Elderly Charles J. Kahi, MD, MSCR Indiana University School of Medicine Richard L. Roudebush VA Medical Center Indianapolis, Indiana ACG Regional Midwest Course Symposium

More information

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm GI Quality Improvement Consortium, Ltd. (GIQuIC) 1 Following is an overview of the clinical quality measures in GIQuIC that can be reported to CMS for the Quality performance category of the Merit-Based

More information

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 David Lieberman MD Chief, Division of Gastroenterology Oregon Health and Science University Portland VAMC Portland, Oregon

More information

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: The

More information

Colorectal Cancer Screening and Surveillance

Colorectal Cancer Screening and Surveillance 1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal

More information

The Importance of Complete Colonoscopy and Exploration of the Cecal Region

The Importance of Complete Colonoscopy and Exploration of the Cecal Region The Importance of Complete Colonoscopy and Exploration of the Cecal Region Kuangi Fu, Takahiro Fujii, Takahisa Matsuda, and Yutaka Saito 2 2.1 The Importance of a Complete Colonoscopy Ever since case-control

More information

Colonoscopy in Rural Communities: Can Family Physicians Perform the Procedure with Safe and Efficacious Results?

Colonoscopy in Rural Communities: Can Family Physicians Perform the Procedure with Safe and Efficacious Results? Colonoscopy in Rural Communities: Can Family Physicians Perform the Procedure with Safe and Efficacious Results? Jeffrey K. Edwards, MD, and Thomas E. Norris, MD Background: Colonoscopy is becoming increasingly

More information

Computed tomographic colonography (CTC), popularly referred

Computed tomographic colonography (CTC), popularly referred CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:237 244 The Management of Small Polyps Found by Virtual Colonoscopy: Results of a Decision Analysis CHIN HUR,*,, DANIEL C. CHUNG,*, ROBERT E. SCHOEN, and

More information

2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)

2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests) Learning Objectives 1. Review principles of colon adenoma/cancer biology that permit successful prevention regimes 2. Describe pros/cons of screening interventions (including colonoscopy, CT colography,

More information

Screening for Colorectal Cancer in Chinese: Comparison of Fecal Occult Blood Test, Flexible Sigmoidoscopy, and Colonoscopy

Screening for Colorectal Cancer in Chinese: Comparison of Fecal Occult Blood Test, Flexible Sigmoidoscopy, and Colonoscopy GASTROENTEROLOGY 2003;124:608 614 Screening for Colorectal Cancer in Chinese: Comparison of Fecal Occult Blood Test, Flexible Sigmoidoscopy, and Colonoscopy JOSEPH J. Y. SUNG,* FRANCIS K. L. CHAN,* WAI

More information

GI Polyp syndromes in children. Screening and surveillance, surgery.

GI Polyp syndromes in children. Screening and surveillance, surgery. Dr Warren Hyer Consultant Paediatric Gastroenterologist St Mark s Hospital, UK GI Polyp syndromes in children Screening and surveillance, surgery. No conflict of interests to declare Objectives Understand

More information

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: The rate of screening

More information

Epidemiology and Treatment of Colonic Angiodysplasia; a Population-Based Study. Naomi G. Diggs, MD Lisa L. Strate, MD MPH March 2, 2010

Epidemiology and Treatment of Colonic Angiodysplasia; a Population-Based Study. Naomi G. Diggs, MD Lisa L. Strate, MD MPH March 2, 2010 Epidemiology and Treatment of Colonic Angiodysplasia; a Population-Based Study. Naomi G. Diggs, MD Lisa L. Strate, MD MPH March 2, 2010 Background Angiodysplasia is an important cause of occult and acute

More information

Colorectal Cancer Screening: A Clinical Update

Colorectal Cancer Screening: A Clinical Update 11:05 11:45am Colorectal Cancer Screening: A Clinical Update SPEAKER Kevin A. Ghassemi, MD Presenter Disclosure Information The following relationships exist related to this presentation: Kevin A. Ghassemi,

More information

COLON CANCER SCREENING: AN UPDATE

COLON CANCER SCREENING: AN UPDATE Overview COLON CANCER SCREENING: AN UPDATE Siddharth Verma, DO, JD Rutgers New Jersey Medical School Background Screening Updates in Specific Populations African Americans CRC in the younger age USPSTF

More information

Frequency of coexistent carcinoma in sessile serrated adenoma/polyps and traditional serrated adenomas removed by endoscopic resection

Frequency of coexistent carcinoma in sessile serrated adenoma/polyps and traditional serrated adenomas removed by endoscopic resection THIEME E451 Frequency of coexistent carcinoma in sessile serrated adenoma/polyps and traditional serrated adenomas removed by endoscopic resection Authors Hirotsugu Saiki 1, Tsutomu Nishida 1, Masashi

More information

Randomised study of screening for colorectal cancer with faecaloccult-blood

Randomised study of screening for colorectal cancer with faecaloccult-blood Articles Randomised study of screening for colorectal cancer with faecaloccult-blood test Ole Kronborg, Claus Fenger, Jørn Olsen, Ole Dan Jørgensen, Ole Søndergaard Summary Background Case-control studies

More information

Optical colonoscopy (OC) is widely accepted as the

Optical colonoscopy (OC) is widely accepted as the Article Location of Adenomas Missed by Optical Colonoscopy Perry J. Pickhardt, MD; Pamela A. Nugent, MD; Pauline A. Mysliwiec, MD, MPH; J. Richard Choi, ScD, MD; and William R. Schindler, DO Background:

More information

Measuring the quality of colonoscopy: Where are we now and where are we going?

Measuring the quality of colonoscopy: Where are we now and where are we going? Measuring the quality of colonoscopy: Where are we now and where are we going? Timothy D. Imler, MD Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 2001 by the Massachusetts Medical Society VOLUME 345 A UGUST 23, 2001 NUMBER 8 ONE-TIME SCREENING FOR COLORECTAL CANCER WITH COMBINED FECAL OCCULT-BLOOD TESTING

More information

Colonoscopy at the National Center for Early Detection of Cancer: Evaluating Indications and Diagnostic Yield

Colonoscopy at the National Center for Early Detection of Cancer: Evaluating Indications and Diagnostic Yield COLONOSCOPY THE IRAQI POSTGRADUATE FOR EARLY MEDICAL DETECTION JOURNAL OF CANCER Colonoscopy at the National Center for Early Detection of Cancer: Evaluating Indications and Diagnostic Yield Maral F.Thabit*,

More information

Pathology of colorectal adenomas: a colonoscopic

Pathology of colorectal adenomas: a colonoscopic J Clin Pathol 1982;35:830-841 Pathology of colorectal adenomas: a colonoscopic survey F KONISHI, BC MORSON From the Department ofpathology, St Mark's Hospital, City Road, London ECJV 2PS SUMMARY The size,

More information